{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:55:46Z","timestamp":1790286946512,"version":"4.1.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:p>This case series describes lipodystrophy, a rare adverse event associated with immune checkpoint inhibitor therapy.<\/jats:p>","DOI":"10.1001\/jamadermatol.2025.0359","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:00:31Z","timestamp":1744210831000},"page":"658","source":"Crossref","is-referenced-by-count":4,"title":["Immune Checkpoint Inhibitor\u2013Induced Lipodystrophy"],"prefix":"10.1001","volume":"161","author":[{"given":"Julia","family":"Riganti","sequence":"first","affiliation":[{"name":"Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Torre","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Sollena","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Mediche e Chirurgiche, Dermatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Koumaki","sequence":"additional","affiliation":[{"name":"Dermatology Department, University Hospital of Heraklion, Heraklion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azael","family":"Freites-Martinez","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Ruber Juan Bravo y Universidad Europea, Madrid, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Delyon","sequence":"additional","affiliation":[{"name":"Department of Dermato-oncology, AP-HP Saint Louis Hospital; Universite Paris Cite; INSERM U976, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Communie","sequence":"additional","affiliation":[{"name":"Service de Dermatologie et V\u00e9n\u00e9r\u00e9ologie, CHU Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Starace","sequence":"additional","affiliation":[{"name":"Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rapparini","sequence":"additional","affiliation":[{"name":"Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[{"name":"First Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Mavroudis","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Hospital of Heraklion, Laboratory of Translational Oncology Medical School, University of Crete, Heraklion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaux","family":"Suzanne","sequence":"additional","affiliation":[{"name":"Dermatology Department, Centre Hospitalier de la C\u00f4te Basque, Bayonne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis D.","family":"Mazzuoccolo","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattheos","family":"Bobos","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Health Sciences at the International Hellenic University, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sibaud","sequence":"additional","affiliation":[{"name":"Oncodermatology Department, Cancer University Institute, Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Apalla","sequence":"additional","affiliation":[{"name":"Second Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece"},{"name":"Dermatologia, Universita Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"dld250005r1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/jdv.17855","article-title":"European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events\u2014the EADV task force \u2018Dermatology for Cancer Patients\u2019 position statement.","volume":"36","author":"Apalla","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"dld250005r2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2337\/db21-1086","article-title":"Characterization and clinical association of autoantibodies against perilipin 1 in patients with acquired generalized lipodystrophy.","volume":"72","author":"Corvillo","year":"2023","journal-title":"Diabetes"},{"issue":"4","key":"dld250005r3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4183\/aeb.2022.516","article-title":"Nivolumab associated endocrine abnormalities: challenging cases from a reference clinic.","volume":"18","author":"Unal","year":"2022","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"2","key":"dld250005r4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bjd.18124","article-title":"Acquired generalized lipodystrophy under immune checkpoint inhibition.","volume":"182","author":"Haddad","year":"2020","journal-title":"Br J Dermatol"},{"issue":"1","key":"dld250005r5","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.4158\/ACCR-2019-0234","article-title":"A case of acquired generalized lipodystrophy associated with pembrolizumab in a patient with metastatic malignant melanoma.","volume":"6","author":"Bedrose","year":"2020","journal-title":"AACE Clin Case Rep"},{"issue":"10","key":"dld250005r6","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.2337\/dc18-2535","article-title":"Acquired generalized lipodystrophy: a new cause of anti\u2013PD-1 immune-related diabetes.","volume":"42","author":"Jehl","year":"2019","journal-title":"Diabetes Care"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2832486\/jamadermatology_riganti_2025_ld_250005_1748911534.20204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:01:14Z","timestamp":1750258874000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2832486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2025.0359","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}